Skip to main content
Figure 5 | Molecular and Cellular Therapies

Figure 5

From: Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies

Figure 5

Differentiation to embryoid bodies from ahiPSCs. The ahiPSCs’ demonstrated by their ability to grow, while aggregating, into embryoid bodies (EB) and to differentiate into three germ layers with the human embryonic stem cells (hESCs, H1, H9) and the PBMCs included as the controls. It was determined by labeling with superparamagnetic antibodies and measuring relaxivity by NMRS and validated by EDXS, while normalized against total amount of protein. Biomarkers: A: myosin heavy chains (MHC); B: neurofilamentous proteins (NF); C: cytokeratins (CK); D: Adrenergic β1 receptor (AdrR); E: Acetylcholine receptor (AChR); F: platelet endothelial cell adhesion molecules (PECAM).

Back to article page